Cargando…

Experimental rat bladder urothelial cell carcinoma models

Bladder cancer is a major public health problem. Currently available therapeutic options seem to be unable to prevent bladder cancer recurrence and progression. To enable preclinical testing of new intravesical therapeutic agents, a suitable bladder tumor model that resembles human disease is highly...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arentsen, Harm C., Hendricksen, Kees, Oosterwijk, Egbert, Witjes, J. Alfred
Formato:	Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2009
Materias:	Topic Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2694312/ https://www.ncbi.nlm.nih.gov/pubmed/19219611 http://dx.doi.org/10.1007/s00345-009-0381-5

Ejemplares similares

Intravesical hyperthermia and mitomycin-C for carcinoma in situ of the urinary bladder: experience of the European Synergo(®) working party
por: Alfred Witjes, J., et al.
Publicado: (2009)

A placebo-controlled efficacy study of the intravesical immunomodulators TMX-101 and TMX-202 in an orthotopic bladder cancer rat model
por: Falke, Johannes, et al.
Publicado: (2018)

Assessment of the efficacy of repeated instillations of mitomycin C mixed with a thermosensitive hydrogel in an orthotopic rat bladder cancer model
por: van Valenberg, F. Johannes P., et al.
Publicado: (2018)

Two-year follow-up of the phase II marker lesion study of intravesical apaziquone for patients with non-muscle invasive bladder cancer
por: Hendricksen, Kees, et al.
Publicado: (2009)

Follow-up in non-muscle invasive bladder cancer: facts and future
por: Witjes, J. Alfred
Publicado: (2020)

Antibody therapy in renal cell carcinoma
por: Oosterwijk, Egbert, et al.
Publicado: (2008)

Utility of pT3 substaging in lymph node-negative urothelial carcinoma of the bladder: do pathologic parameters add to prognostic sub-stratification?
por: Maas, Moritz, et al.
Publicado: (2021)

Impact of sex on outcomes after surgery for non-muscle-invasive and muscle-invasive bladder urothelial carcinoma: a systematic review and meta-analysis
por: Mori, Keiichiro, et al.
Publicado: (2022)

Combined radiotherapy and immunotherapy in urothelial bladder cancer: harnessing the full potential of the anti-tumor immune response
por: Daro-Faye, Mame, et al.
Publicado: (2020)

Volumetric imaging: a potential tool to stage upper tract urothelial carcinoma
por: Grahn, Alexandra, et al.
Publicado: (2019)

Consultation on UTUC, Stockholm 2018 aspects of diagnosis of upper tract urothelial carcinoma
por: Fojecki, Grzegorz, et al.
Publicado: (2019)

The clonal relation of primary upper urinary tract urothelial carcinoma and paired urothelial carcinoma of the bladder
por: van Doeveren, Thomas, et al.
Publicado: (2020)

Predicting invasiveness and disease-specific survival in upper tract urothelial carcinoma: identifying relevant clinical tumour characteristics
por: Malm, Camilla, et al.
Publicado: (2019)

Device-assisted intravesical therapy for non-muscle invasive bladder cancer
por: Hendricksen, Kees
Publicado: (2019)

Pseudoprogression and hyperprogression during immune checkpoint inhibitor therapy for urothelial and kidney cancer
por: Soria, Francesco, et al.
Publicado: (2018)

Role of angiogenesis in urothelial bladder carcinoma
por: Fus, Łukasz Piotr, et al.
Publicado: (2016)

Do Orthotopic Ileal Diversions Induce Immunological Changes in Retained Urethral Tissue?
por: Niegisch, Günter, et al.
Publicado: (2015)

Impact of sex on the efficacy of immune checkpoint inhibitors in kidney and urothelial cancers: a systematic review and meta-analysis
por: Yanagisawa, Takafumi, et al.
Publicado: (2023)

Molecular markers in bladder cancer
por: Soria, Francesco, et al.
Publicado: (2018)

The role of cell adhesion molecules in the progression of bladder urothelial carcinomas
por: Săndulescu, Andrei Ştefan, et al.
Publicado: (2022)

Curcumin as Treatment for Bladder Cancer: A Preclinical Study of Cyclodextrin-Curcumin Complex and BCG as Intravesical Treatment in an Orthotopic Bladder Cancer Rat Model
por: Falke, J., et al.
Publicado: (2018)

DPPG(2)-Based Thermosensitive Liposomes with Encapsulated Doxorubicin Combined with Hyperthermia Lead to Higher Doxorubicin Concentrations in the Bladder Compared to Conventional Application in Pigs: A Rationale for the Treatment of Muscle-Invasive Bladder Cancer
por: van Valenberg, F Johannes P, et al.
Publicado: (2021)

Detection of specific chromosomal aberrations in urine using BCA-1 (oligo-CGH-array) enhances diagnostic sensitivity and predicts the aggressiveness of non-muscle-invasive bladder transitional cell carcinoma
por: Cussenot, Olivier, et al.
Publicado: (2013)

Giant Cell Urothelial Carcinoma of Bladder
por: Wijesinghe, Harshima Disvini, et al.
Publicado: (2021)

Economic aspects of bladder cancer: what are the benefits and costs?
por: Sievert, K. D., et al.
Publicado: (2009)

The present and future burden of urinary bladder cancer in the world
por: Ploeg, Martine, et al.
Publicado: (2009)

En bloc resection of bladder tumour: the rebirth of past through reminiscence
por: Teoh, Jeremy Yuen-Chun, et al.
Publicado: (2023)

Clinical, demographic and histopathological prognostic factors for urothelial carcinoma of the bladder
por: Kucuk, Ulku, et al.
Publicado: (2015)

Immunoexpression of N-cadherin, Twist and Vimentin in Bladder Urothelial Carcinomas
por: STEPAN, A.E., et al.
Publicado: (2015)

Maximum tumor diameter is not an independent prognostic factor in high-risk localized prostate cancer
por: van Oort, I. M., et al.
Publicado: (2008)

Protein Profiling of Bladder Urothelial Cell Carcinoma
por: Hu, Jinghai, et al.
Publicado: (2016)

MiR-25 regulates cell proliferation and metastasis in bladder urothelial carcinoma
por: Ning, Jin-zhuo, et al.
Publicado: (2021)

Establishing the prediction models for recurrence and progression of T1G3 bladder urothelial carcinoma
por: Chen, Song, et al.
Publicado: (2019)

Genomics and clinical correlates of renal cell carcinoma
por: Mitchell, Thomas J., et al.
Publicado: (2018)

The fish-hook configuration of the distal ureter indicates bladder outlet obstruction due to benign prostatic hyperplasia
por: Mamoulakis, Charalampos, et al.
Publicado: (2010)

Intravesical therapy for urothelial carcinoma of the bladder
por: Manoharan, M.
Publicado: (2011)

Bladder melanosis with concurrent urothelial carcinoma
por: Yau, Susanna E., et al.
Publicado: (2017)

Cutaneous metastasis of bladder urothelial carcinoma
por: Hasan, Osamah, et al.
Publicado: (2019)

Molecular classification of urothelial bladder carcinoma
por: Schwarzova, Lucia, et al.
Publicado: (2023)

The role of aberrant promoter hypermethylation of DACT1 in bladder urothelial carcinoma
por: Cheng, Huan, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_cstffovr78dgg7n913jqr62osb